Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL
Title:
Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL
Author:
Porter, David L. Kalos, Michael Frey, Noelle V. Grupp, Stephan A. Loren, Alison W. Jemison, Christina Gilmore, Joan McConville, Holly Capobianchi, James Lledo, Lester Chew, Anne Zheng, Zhaohui Levine, Bruce L. June, Carl H.